According to the latest data from the Stock Exchange of Hong Kong, JPMorgan Chase & Co. increased its holding in Tigermed (03347) by approximately 566,578 shares on July 17th.

The transaction was executed at an average price of around HK$36.84 per share, involving a total consideration of approximately HK$20.87 million.

Following this acquisition, JPMorgan's total shareholding in the company has risen to roughly 21.34 million shares.

This represents a stake of about 17.32% in the company.